Oct 02, 2025
463:360
For every 360 shares held, investors received 463. The price per share adjusted from $0.52 to $0.41.
The split itself did not change the total investment value.
Immunovia AB (STO:IMMNOV) operates in the Pharmaceuticals: major industry.
Immunovia AB company overviewImmunovia AB's most recent stock split was on October 2, 2025. It was a 463-for-360 forward split, so shareholders received 463 shares for every 360 they held.
Immunovia AB (STO:IMMNOV) has split its stock 3 times: a 139-for-129 split on March 20, 2023, a 155-for-77 split on August 13, 2024, and a 463-for-360 split on October 2, 2025.
Immunovia AB has split its stock 3 times. This history records 3 forward splits between March 20, 2023 and October 2, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Immunovia AB's 463-for-360 split on October 2, 2025, every 360 shares became 463 shares.
Immunovia AB has not announced a new split in our records. Its most recent split was on October 2, 2025, 1 year ago. Companies announce splits in advance, and any new STO:IMMNOV split will appear on this page.
Already premium?